Publicações
- Furnival-Adams, J., Kiuru, C., Sagna, A.B. et al. Ivermectin resistance mechanisms in ectoparasites: a scoping review. Parasitol Res 123 (2024). https://doi.org/10.1007/s00436-024-08223-z
- Karisa, J., Ominde, K., Tuwei, M. et al. Utility of MALDI-TOF MS for determination of species identity and blood meal sources of primary malaria vectors on the Kenyan coast. Wellcome Open Research 8 (2024). https://doi.org/10.12688/wellcomeopenres.18982.2
- Chaccour, C., Casellas, A., Hammann, F. et al. BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa—a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings. Trials 24, 128 (2023). https://doi.org/10.1186/s13063-023-07098-2
- Ruiz-Castillo, P., Imputiua, S., Xie, K. et al. BOHEMIA a cluster randomized trial to assess the impact of an endectocide-based one health approach to malaria in Mozambique: baseline demographics and key malaria indicators. Malar J 22, 172 (2023). https://doi.org/10.1186/s12936-023-04605-3
- O’Bryan, E., Imputiua, S., Elobolobo, E. et al. Burden and risk factors of snakebite in Mopeia, Mozambique: Leveraging larger malaria trials to generate data of this neglected tropical disease. PLoS Neglected Tropical Diseases (2023). https://doi.org/10.1371/journal.pntd.0011551
- Kiuru, C., Ominde, K., Muturi, M. et al. Effects of larval exposure to sublethal doses of ivermectin on adult fitness and susceptibility to ivermectin in Anopheles gambiae s.s. Parasites & Vectors 16 (2023). https://doi.org/10.1186/s13071-023-05888-w
- Kern, C., Müller, P., Chaccour, C. et al. Pharmacokinetics of ivermectin metabolites and their activity against Anopheles stephensi mosquitoes. Malaria Journal 22 (2023). https://doi.org/10.1186/s12936-023-04624-0
- Ominde, K., Kamau, Y., Karisa, J. et al. A field bioassay for assessing ivermectin bio-efficacy in wild malaria vectors. Malaria Journal 22 (2023). https://doi.org/10.1186/s12936-023-04718-9
- Xie, K., Marathe, A., Deng, X. et al. Alternative approaches for creating a wealth index: the case of Mozambique. BMJ Global Health 8 (2023). https://doi.org/10.1136/bmjgh-2023-012639
- Kamau Y, Tuwei M, Wanjiku C, Ominde K, Ngama M, Karisa J, Babu L, Muturi M, Mwatasa M, Adetifa J, Kern C, Duthaler U, Hammann F, Rabinovich R, Chaccour C, Maia MF. Mosquitocidal efficacy and pharmacokinetics of single-dose ivermectin versus three-day dose regimen for malaria vector control compared with albendazole and no treatment: An open-label randomized controlled trial. Int J Infect Dis. 2024 Nov;148:107236. doi: 10.1016/j.ijid.2024.107236.
- Nicolas, P., Imputiua, S., Elobolobo, E. et al. Access and usage of malaria control measures by women of reproductive age in Mopeia Mozambique. Malar J 24, 66 (2025). https://doi.org/10.1186/s12936-025-05306-9
- Onyango, T., Nuru, K., Kazungu, K. et al. Through the eyes of the participant: using photovoice to understand the experiences and effects of ivermectin MDA in the context of the BOHEMIA clinical trial in Kwale, Kenya. Malar J 24, 79 (2025). https://doi.org/10.1186/s12936-025-05320-x
- Kiuru, C., Constantino, L., Cole, G. et al. Multiple insecticide resistance in Anopheles funestus from Mopeia, Central Mozambique. Malar J 24, 81 (2025). https://doi.org/10.1186/s12936-025-05321-w
- Furnival-Adams, J., Houana, A., Nicolas, P. et al. Collateral benefits of ivermectin mass drug administration designed for malaria against headlice in Mopeia, Mozambique: a cluster randomised controlled trial. Infect Dis Poverty 14, 25 (2025). https://doi.org/10.1186/s40249-025-01290-z
